This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

ITCH - Case 4 - Adult AD: Refractory to Treatment

ITCH - Case 4 - Adult AD: Refractory to Treatment


Slide Lecture Series

Time to Complete

15 minutes


June 6, 2017


June 6, 2018
Add to Queue

Maximum Credits

0.25 / AMA PRA Category 1 CreditTM

Accredited Provider

Jointly provided by Clinical & Patient Educators Association and CME Solutions

Commercial Supporter

This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Program Description

The ITCH Digital Library is an interactive, flexible series of mini-modules grouped into learning categories:

Immune and Barrier Dysfunction
Toolkit for Multidisciplinary Approach to Patient Care
Hope on the Horizon (emerging therapies)

The program focuses on the identified educational needs of both specialists and primary care practitioners, including disease overview, differential diagnosis, referral checklists, treatment plans for ongoing management between specialist visits, etc. Learners can customize their learning by completing modules that align with their educational needs.

Intended Audience

Dermatologists, immunologists, allergists, pediatricians, and primary care practitioners

Educational Objectives

Upon completion of these activities, participants should be better able to:

  • Address common triggers for adult atopic dermatitis (AD)
  • Outline therapeutic options and strategies to treat refractory AD
  • Identify appropriate adult candidates for systemic therapy
  • Identify and counsel patients regarding real and perceived barriers to safe, sustainable therapy

Conflict Of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities, it is CPEA’s policy to ensure balance, independence, objectivity and scientific rigor in all of its continuing medical education (CME) activities.

CPEA requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CME activity certified by CPEA.

Disclosures received by CPEA from individuals in a position to control CME content are made transparent to learners prior to participating in the activity. CPEA discloses the following information to learners: 1) the name of the individual, 2) the name of the commercial interest(s), and 3) the nature of the relationship the individual has with the commercial interest. CPEA also discloses to learners the name(s) of commercial interests supporting each CME activity.

Once a conflict is identified, a content validation process is initiated to ensure that the content or format of the CME activity and related materials will promote improvements or quality in healthcare and not promote a specific proprietary business interest of a commercial interest. To this end, CPEA will conduct an unbiased review of all planned content for CME activities certified for credit to ensure adherence to the ACCME content validation statements and to resolve any actual or perceived conflict of interest that exists. CPEA employs three primary metrics to validate CME content: 1) fair balance, 2) the scientific objectivity of studies mentioned in the materials or used as the basis for content, and 3) appropriateness of patient care recommendations made to learners.

All faculty receive instructions via confirmation letters that communicate CPEA’s standards of practice in CME. Specifically, information concerning expectations related to content validation and safeguards against commercial bias. Individual presentations or initial drafts of a conflicted faculty member’s content are reviewed by a CPEA’s clinical staff. If there are concerns identified by the content validation process, feedback may be requested from the Program Chair, and if necessary, a separate expert peer review is conducted under the direction of the CPEA. CPEA requests that learners evaluate activities for the potential presence of bias.


Robert Sidbury, MD MPH
Department of Pediatrics - Division Chief
Seattle Children’s Hospital
Associate Professor, Adjunct
Division of Dermatology
Department of Medicine
University of Washington
Seattle, WA

Dr. Sidbury has disclosed that he conducted research for Anacor, Pierre Fabre, Sanofi-Regeneron, and Scioderm and is a consultant for Roche.

Lynda Schneider, MD
Director, Allergy Program
Boston Children’s Hospital
Professor of Pediatrics
Harvard Medical School
Boston, MA

Dr. Schneider has disclosed that she received research funding from Regeneron and is on the advisory board for Anacor.

Timothy Berger, MD
University of California San Francisco Medical Center
Professor of Clinical Dermatology
University of California San Francisco
San Francisco, CA

Dr. Berger has no disclosures to report.

Accredited Provider Disclosure

Andrea Funk has no disclosures to report.

Publishing Staff Disclosures

Lynn Heywood-McLean has no disclosures to report.
Sarah Scheigetz has no disclosures to report.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

CPEA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

CPEA designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Clinical and Patient Educator’s Association (CPEA) and CME Solutions do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.


To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact Clinical and Patient Educators Association at 303-953-4580 or

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue